Pietro Carotenuto

Via Campi Flegrei 34, Pozzuoli
Naples, 80078, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Genetic discrimination in workplace, insurance industry and legal system: A review.

Genetic discrimination in workplace, insurance industry and legal system: A review.

Journal: Legal medicine (Tokyo, Japan)

Published: August 12, 2025

uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells.

uL3 Regulates Redox Metabolism and Ferroptosis Sensitivity of p53-Deleted Colorectal Cancer Cells.

Journal: Antioxidants (Basel, Switzerland)

Published: June 03, 2024

RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy.

RNA-Based Next-Generation Sequencing in Non-Small Cell Lung Cancer patients: data from Campania, Italy.

Journal: Pathologica

Published: April 19, 2024

A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers.

A MiR181/Sirtuin1 regulatory circuit modulates drug response in biliary cancers.

Journal: Clinical and experimental medicine

Published: January 25, 2024

Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies.

Cilia and Cancer: From Molecular Genetics to Therapeutic Strategies.

Journal: Genes

Published: June 07, 2023

Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells.

Combining β-Carotene with 5-FU via Polymeric Nanoparticles as a Novel Therapeutic Strategy to Overcome uL3-Mediated Chemoresistance in p53-Deleted Colorectal Cancer Cells.

Journal: Molecular pharmaceutics

Published: March 28, 2023

The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth.

The NAMPT Inhibitor FK866 in Combination with Cisplatin Reduces Cholangiocarcinoma Cells Growth.

Journal: Cells

Published: November 29, 2022

CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice.

CtDNA-guided rechallenge with anti-EGFR therapy in RASwt metastatic colorectal cancer: Evidence from clinical practice.

Journal: Tumori

Published: September 16, 2022

Thyroid Cancer and Fibroblasts.

Thyroid Cancer and Fibroblasts.

Journal: Cancers

Published: July 15, 2022

Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.

Generation and Characterization of a Tumor Stromal Microenvironment and Analysis of Its Interplay with Breast Cancer Cells: An In Vitro Model to Study Breast Cancer-Associated Fibroblast Inactivation.

Journal: International journal of molecular sciences

Published: May 06, 2022

Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.

Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.

Journal: Expert review of gastroenterology & hepatology

Published: December 10, 2021

Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy.

Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy.

Journal: Cancer management and research

Published: November 27, 2021

Showing 1-12 of 27

Last Updated: 09/26/2026